GHR Foundation
  • Impact Areas
    • Global Engagement >
      • Children in Families
      • Prepare The Future
      • Programs in Transition >
        • BridgeBuilder >
          • Overview
          • 2017 Top Ideas >
            • Peace Direct
            • BioCarbon Engineering
            • LIFT Chicago
            • Local Youth Corner Cameroon
            • NaTakallam
          • 2018 Top Ideas >
            • This is My Backyard
            • Found in Translation
            • Producers Direct
            • War Child Canada
            • My Choices Foundation
          • 2019 Top Ideas >
            • Top Manta
            • Five One Labs
            • SAMA for All
            • Talent Beyond Boundaries
            • FaithAction
        • Inter-Religious Action
        • Sister Support
    • Education >
      • Catholic Schools
      • Higher Education
    • Twin Cities Racial Equity
    • Alzheimer's
  • News
  • About Us
    • The Foundation
    • History & Legacy
    • Team >
      • Staff
      • Committees
      • Board
    • FAQs
    • Grants & Financials
  • Contact

Catholic Spirit: Dual-language Risen Christ Catholic School in Minneapolis ascends to new life

5/24/2022

0 Comments

 
Picture
From left, first-grader Leo Vega, fifth-grader Immanuel Rowland, first-grader Ian Montano Alarcon and fifth-grader Camila Lopez listen during Mass April 21 at Holy Name Church adjacent to Risen Christ Catholic School. DAVE HRBACEK | THE CATHOLIC SPIRIT
From The Catholic Spirit:

"Founded in 1993 out of five Minneapolis Catholic schools — Holy Name, Holy Rosary, Incarnation, St. Albert the Great and St. Stephen — Risen Christ is best known for its immersion program. With the school’s “50/50 model,” students receive 50% of their instruction in English each day and 50% in Spanish. Every student receives daily instruction in English and Spanish literacy. Grade-level teaching teams include one teacher fluent in English and one fluent in Spanish.

The effort began with the fall 2014 kindergarten class, and one grade has been added each year. Today, only eighth-graders did not start under the immersion program.

That model attracted Sonia Rosas, 28, of Minneapolis, and her husband, Jose, to Risen Christ. They have a 10-year-old daughter in third grade, and a 6-year-old daughter in kindergarten. In choosing the school, Sonia Rosas said it was important that students learn in Spanish and English, that it is a Catholic school, and she heard that people at the school “are very supportive with families and have a deep understanding (of) the culture and the language.”"

Read more. 
0 Comments

GHR Partner C2N Diagnostics Introduces P-tau Multi-Analyte Assay for Research Use Only to Advance Alzheimer’s Disease and Brain Health Field

5/18/2022

0 Comments

 
C2N Diagnostics’ Alzheimer's blood test was introduced into the clinic in October of 2020, a breakthrough healthcare innovation for patients, advocates, and physicians who have long awaited an easy to administer test that can help them better understand Alzheimer’s disease. C2N developed this groundbreaking test based upon longtime GHR partner Dr. Randall Bateman’s initial discovery of how to measure amyloid proteins in blood, validating its results in a clinical trial of 686 patients. 

From C2N Diagnostics: 


"C2N Diagnostics today announced its latest innovative offering for enhancing care in brain health: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA) for Research Use Only (RUO). 

This assay uses a small sample of blood to precisely and simultaneously measure different phosphorylated and nonphosphorylated forms of the tau protein, including forms with phosphorylation at the tau217 and tau181 sites. The assay draws upon prior discoveries by medical researchers that complex interactions among abnormal tau and beta-amyloid proteins and several other factors play a vital role in Alzheimer’s-related brain changes."

​Read more. 
0 Comments

NIH: NAPA at 10: A decade of Alzheimer’s and related dementias research progress, including GHR partner C2N Diagnostics PrecivityAD™ test

5/17/2022

0 Comments

 
Picture
From the NIH National Institute on Aging:

"As we mark the 10-year anniversary of the National Plan to Address Alzheimer’s Disease, which arose from the National Alzheimer's Project Act (NAPA), it’s striking to pause for a moment and consider how far we have come. Thanks to increased congressional funding, NIH spending on Alzheimer’s and related dementias research advanced nearly 4.5-fold between fiscal years 2015 and 2020, reaching $2.87 billion. This momentum has enabled NIA-funded science to take significant strides forward.

NIA small business innovation research funding helped validate and commercialize the PrecivityAD™ test, a more affordable and less invasive alternative to traditional Alzheimer’s tests like spinal taps or brain scans. This blood biomarker-based test is now widely available to doctors and researchers across the United States."

​Read more.


0 Comments

NIH: Blood test can predict presence of beta-amyloid in the brain, new study finds

5/11/2022

0 Comments

 
Picture
From the National Institute on Aging at NIH:
​
Scientists have demonstrated that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain, according to a new study funded in part by NIA. Published in Neurology, the study analyzed the ability of a blood test to predict the presence of Alzheimer’s disease-associated protein beta-amyloid in the brain. The new blood test, which performs comparably to existing brain scan- or spinal tap-based tests, could lower costs and expand the availability of diagnostic studies for Alzheimer’s disease.

Read more.
0 Comments

[VIDEO] Soledad O'Brien: COVID-19 Long Haulers Struggle to Access Medical Care

5/6/2022

0 Comments

 
Picture
From Matter of Fact With Soledad O'Brien:

'As mask mandates fade away, Matter of Fact looks at the Americans — up to 23 million — who are still suffering from long haul symptoms like memory loss and physical exhaustion. Dina Demetrius reports from Los Angeles on how many are struggling to get the necessary medical care, with one explaining how she feels “gaslit.”'
0 Comments

USA Today: Scientists are studying blood tests for dementia: 'A new era of diagnosis for Alzheimer's disease'

5/6/2022

0 Comments

 
Picture
.From USA Today:

  • New blood tests could offer easier way to detect signs of the disease in older adults with memory issues
  • The tests may be helpful in identifying subjects for clinical trials or to screen for treatment.
  • Alzheimer’s disease afflicts an estimated 6.5 million Americans.

As pharmaceutical companies spend hundreds of millions of dollars on a potential treatment for Alzheimer’s disease, other researchers are focusing on a more elemental question.

How can you tell whether a family member or loved one has Alzheimer’s or another form of dementia?

Read more.
0 Comments

    Categories

    All
    Africa
    Alzheimer's
    Annual Report
    BridgeBuilder
    Cambodia
    Catholic Schools
    Central African Republic
    Children In Families
    Coverage
    COVID 19
    COVID-19
    Design Build
    Education
    Faith & Development
    Global
    Global Development
    Health
    Higher Education
    Inter-Religious Action
    Kenya
    Legacy
    Myanmar
    Nepal
    Nigeria
    Podcast
    Sister Support
    Solutions
    Twin Cities Racial Equity
    Uganda
    U.S.
    Work Of The Church
    Zambia

    Archives

    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    December 2018
    November 2018
    October 2018
    September 2018
    June 2018
    May 2018
    April 2018
    February 2018
    January 2018
    November 2017
    October 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    January 2017
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    August 2014
    July 2014
    May 2014
    April 2014
    March 2014
    October 2013
    December 2012

    RSS Feed

CONNECT WITH US

IMPACT AREAS  |  NEWS  |  ABOUT  |  JOBS  | ​ CONTACT  
Privacy Policy  |  Terms of Use
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
©2022 GHR FOUNDATION
All Rights Reserved.